Sunitinib

CHEMBL535 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
398.5 g/mol
LogP
2.6
Phase
4

A multi-targeted tyrosine kinase inhibitor that blocks several receptors on tumor cells and their blood supply simultaneously, used for kidney cancer, gastrointestinal stromal tumors, and certain pancreatic tumors. By cutting off the tumor's blood supply and directly inhibiting cancer cell growth signals, it helps slow or stop tumor progression.

Molecular Weight

398.5000 g/mol

LogP

2.60

TPSA

77.20 Ų

Lipinski RO5

Pass

Therapeutic Areas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C

InChI

InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-

Molecular Formula

C22H27FN4O2

HBD / HBA

3 / 4

Rotatable Bonds

7

Heavy Atoms

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A multi-targeted tyrosine kinase inhibitor that blocks several receptors on tumor cells and their blood supply simultaneously, used for kidney cancer, gastrointestinal stromal tumors, and certain pancreatic tumors. By cutting off the tumor's blood supply and directly inhibiting cancer cell growth signals, it helps slow or stop tumor progression.

Yes, Sunitinib is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL535. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5329102. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.